March 2016, Latitude Health report for the Chinese launch of telemedicine market development "Telemedicine: values, challenges and opportunities", the report of the China market to make telemedicine a more in-depth and comprehensive analysis, the report notes, telemedicine in China The development is more difficult to achieve explosive growth. Regional and small scale will be the main development characteristics of telemedicine in the future. Moreover, due to the influence of policies, telemedicine faces greater uncertainty. Telemedicine, which is based on teleconsultation, has been developed for decades, but it has always been limited to medical institutions and is a very niche market. With the development of technology and the demand for medical control fees, telemedicine began to face the public directly, providing solutions for conventional diseases. In this development process, the demand of the payer for the control fee is the most important driving force, and the demand for convenience is only the result of market development rather than the driving force. With the official implementation of the health care reform bill in the United States in 2013, all types of telemedicine services have developed rapidly. Most telemedicine services have been in operation for many years, and did not achieve high growth before Obama's medical reform, mainly because the payers did not tilt towards such services, and most of them were not included in the scope of compensation. In the absence of federal government and commercial claims, it is difficult to open the market at its own expense. The fastest growth of this year's round of telemedicine in the United States is the remote consultation for group users, featuring small illnesses. The main representative of this model is Teladoc, which was listed in the US in July 2015. At the same time, telemedicine for major illnesses, specialties and emergency departments has also made considerable progress. These models directly reduce the price of the consultation and are beneficial to cost control. In contrast, the growth of the remote monitoring market, where the role of fees and charges is not clear, is not rapid. Compared with the US market, the effect of China's telemedicine control fees cannot be reflected. The driving force is mainly due to the transformation of the overall medical service model. The overall price of offline medical services in China has been depressed for a long time, and even the development of telemedicine cannot directly reduce costs. Moreover, the main income of Chinese medical institutions and doctors comes from products, and the implementation of telemedicine will force them to transfer the benefits of products, which is one of the biggest resistance of telemedicine in China. However, with the increasing demand for medical control fees due to aging and medical insurance, the development of China's existing medical system has been unable to bear the needs of the market. It is urgent to move from the original service model with large hospitals as the core to the multi-level and multi-institutional three-dimensional Medical service network transformation. In this transformation process, the service shortcomings of the primary and secondary medical institutions that were originally poor and weak are urgently needed to be supplemented, and telemedicine will become a good complement. In such a transformation process, telemedicine will become the hub of the service network formed by large hospitals, specialist hospitals and grassroots units, and ultimately help China's medical system shift from a doctor-centered model to a patient-centered model. . However, the development of telemedicine in China still has a long way to go from ideal to reality. The current challenges of telemedicine are very large. The lack of mature electronic medical record system, the unclear payment of medical insurance, the fragmentation of the national medical insurance system, and the unfavourable factors of doctors being guided by products have greatly restricted the growth of the telemedicine market. Due to the above multiple conditions, China's telemedicine will be more of a regional market, the overall development will not be too fast, and the market development uncertainty is strong, the market size in the short to medium term will not be too large. Unlike the US market, the development of telemedicine in China requires heavy participation and layout. The current operation in the light asset model is more like a remote ECG diagnosis and monitoring model that does not have a high burden on both the supply and demand sides. Although operating in a light asset model, the development of remote reading is clearly limited. Because China's third-party imaging centers are very weak, it is necessary to invest heavily in equipment to develop remote readings. This has become a very heavy model. The development of remote consultation is affected by the development of offline medical models, and it is necessary to communicate and coordinate the interests of large hospitals, specialist hospitals and grassroots parties. Different from the mature payment and evaluation standards in the US market, China's telemedicine needs to find a set of standards that can be recognized by the market in practice to truly promote the development of telemedicine. In short, the development of telemedicine in China will not be explosive, but the value is very large and will become an important means of reform of the entire medical system.
Electronic smart digital Upper arm and Wrist Blood Pressure Monitor automatic.
we are manufacturer of Blood pressure monitor for more than 12 years, we can accept OEM/ODM as for your requirements.
More closer to our peoples' heart, so the result of measurement will be more accurate.
Main Feautures For Electronic Sphygmomanometer Automatic BP Machine Digital Upper Arm Blood Pressure Monitor:
· Measurement method: oscillometric method
· Display screen: LCE big digital display shows high pressure / low pressure / pulse
· Blood pressure classification: WHO sphygmomanometer classification indicates blood pressure health
· Intelligent pressurization: automatic pressurization and decompression, IHB heart rate detection
· Year/month/day time display
· 2*90sets of measurement results memory for two people; the average reading of the last 3 measurements for data comparison
· One button measuremment,automatic turn on-off for convenient operation
· Blood pressure value unit Kpa and mmHg for conversion (boot default unit is mmHg)
· voice broadcast function is optional,any OEM demand available
electronic sphygmomanometer:arm sphygmomanometer:aneroid sphygmomanometer:sphygmomanometer digital: Shenzhen Urion Technology Co., Ltd. , https://www.urionhealth.com
Comfortable cuff included